NCT02504606View on ClinicalTrials.gov

Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Hypertension
Interventions
DRUG

Besylsartan

Amlodipin besylate 6.944mg+Losartan K 100mg

DRUG

Amosartan

Amlodipin besylate 7.841mg+Losartan K 100mg

All Listed Sponsors
lead

Huons Co., Ltd.

INDUSTRY

NCT02504606 - Safety and Pharmacokinetics of Besylsartan Tablet in Healthy Male Subject | Biotech Hunter | Biotech Hunter